Review



mircury microarray labeling kit  (Qiagen)


Bioz Manufacturer Symbol Qiagen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Qiagen mircury microarray labeling kit
    miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a <t>microarray</t> analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.
    Mircury Microarray Labeling Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mircury microarray labeling kit/product/Qiagen
    Average 90 stars, based on 1 article reviews
    mircury microarray labeling kit - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "Hypoxia Enhances Activity and Malignant Behaviors of Colorectal Cancer Cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT Axis"

    Article Title: Hypoxia Enhances Activity and Malignant Behaviors of Colorectal Cancer Cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT Axis

    Journal: Analytical Cellular Pathology (Amsterdam)

    doi: 10.1155/2021/4132488

    miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a microarray analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.
    Figure Legend Snippet: miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a microarray analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.

    Techniques Used: Cell Culture, Microarray, Expressing, Quantitative RT-PCR



    Similar Products

    mircury microarray labeling kit  (Qiagen)
    90
    Qiagen mircury microarray labeling kit
    miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a <t>microarray</t> analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.
    Mircury Microarray Labeling Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mircury microarray labeling kit/product/Qiagen
    Average 90 stars, based on 1 article reviews
    mircury microarray labeling kit - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a microarray analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.

    Journal: Analytical Cellular Pathology (Amsterdam)

    Article Title: Hypoxia Enhances Activity and Malignant Behaviors of Colorectal Cancer Cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT Axis

    doi: 10.1155/2021/4132488

    Figure Lengend Snippet: miR-19a is upregulated in the hypoxia-exposed CRC cells: (a) differentially expressed miRNAs between CRC cells cultured under hypoxic and normoxic conditions screened using a microarray analysis; (b) expression of miR-19a in HCT116 and SW480 cells cultured under hypoxic and normoxic conditions validated by RT-qPCR ( ∗ p < 0.05, two-way ANOVA); (c) expression of miR-19a in cancer and paracancerous tissues from CRC patients examined by RT-qPCR ( ∗ p < 0.05, paired t -test); (d) relevance of miR-19a expression to the survival of patients ( ∗ p < 0.05, Kaplan-Meier analysis); (e) relevance of miR-19a expression to the clinical characteristics of patients; (f) expression of miR-19a in HCT116 and SW480 and in normal NCM460 cells determined by RT-qPCR ( ∗ p < 0.05, one-way ANOVA). Data were presented as the mean ± SD from three independent experiments.

    Article Snippet: The isolated miRNAs were labeled with Hy3 using a miRCURY microarray labeling kit (Exiqon) and then hybridized using a miRCURY LNA miRNA Array (v.8.0, Exiqon).

    Techniques: Cell Culture, Microarray, Expressing, Quantitative RT-PCR